// App-Quantinova.ai

2016 : Inhibition Of S100A6 Induces Graft Versus Leukemia Effects In MLL/AF4-Positive ALL In Human PBMC-SCID Mice

Researchers

Presenter

  • Hayato Tamai

Principal Investigators

  • Hiroki Yamaguchi

  • Kazuo Dan

  • Koiti Inokuchi

Medical Centers

  • Department of Urology, Nippon Medical School Hospital, Tokyo, Japan

  • Division of Hematology, Department of Medicine, Nippon Medical School, Tokyo, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

  • Peripheral blood mononuclear cell

Drug/Treatment

  • Allopurinol

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim